Paul W.M. Fedak
-
- Cardiac Valve Diseases and Treatments 47
- Cardiac Fibrosis and Remodeling 34
- Cardiovascular Function and Risk Factors 17
- Pulmonary and Respiratory Medicine top 0.5%
- Aortic Disease and Treatment Approaches 49
- Aortic aneurysm repair treatments 35
- Epidemiology top 0.5%
- Surgery top 0.5%
- Tissue Engineering and Regenerative Medicine 32
- Cardiac Structural Anomalies and Repair 29
- Biochemistry top 1%
-
- Electrospun Nanofibers in Biomedical Applications 21
Paul W.M. Fedak
178 papers receiving 10.8k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Cardiology and Cardiovascular Medicine 5.4k
- Pulmonary and Respiratory Medicine 3.2k
- Epidemiology 2.8k
- Surgery 3.2k
- Biochemistry 356
Countries citing papers authored by Paul W.M. Fedak
This map shows the geographic impact of Paul W.M. Fedak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul W.M. Fedak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul W.M. Fedak more than expected).
Fields of papers citing papers by Paul W.M. Fedak
This network shows the impact of papers produced by Paul W.M. Fedak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul W.M. Fedak. The network helps show where Paul W.M. Fedak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul W.M. Fedak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 90 | |
| 11 | 2021 | 3 | |
| 12 | 2020 | 26 | |
| 13 | 2019 | 128 | |
| 14 | 2019 | 18 | |
| 15 | 2017 | 6 | |
| 16 | 2016 | 14 | |
| 17 | 2013 | 62 | |
| 18 | Abstract 1478: Angiogenesis After a Myocardial Infarction is Regulated by Bone Marrow c-kit+ Cells | 2006 | 1 |
| 19 | 2005 | 46 | |
| 20 | 2004 | 65 |
About Paul W.M. Fedak
Paul W.M. Fedak is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Biomaterials, having authored 181 papers that have together received 11.1k indexed citations. Recurring topics across this work include Aortic Disease and Treatment Approaches (49 papers), Cardiac Valve Diseases and Treatments (47 papers), Aortic aneurysm repair treatments (35 papers), Cardiac Fibrosis and Remodeling (34 papers), Tissue Engineering and Regenerative Medicine (32 papers), Cardiac Structural Anomalies and Repair (29 papers), Electrospun Nanofibers in Biomedical Applications (21 papers) and Cardiovascular Function and Risk Factors (17 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (5.4k citations), Pulmonary and Respiratory Medicine (3.2k citations) and Epidemiology (2.8k citations). Paul W.M. Fedak has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Subodh Verma, Richard D. Weisel, Ren‐Ke Li, Donald A.G. Mickle, Chao‐Hung Wang, Shuhong Li, Mitesh Badiwala, Jagdish Butany, Paul E. Szmitko and Tirone E. David. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.